Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Slowing the spread of fentanyl in Canada would require legislative and policing changes that could allow law enforcement to ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...